Codes / ICD10CM / T48.293

T48.293 Poisoning by other drugs acting on muscles, assault

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by other drugs acting on muscles, assault

Summary

This condition involves poisoning by drugs that act on muscles, resulting from an assault. It includes clinical effects from intentional exposure to these medications, typically due to ingestion or administration with the intent to harm, where the specific agent is classified as "other" (not otherwise specified).

Causes

Assault-related poisoning may result from deliberate administration or forced ingestion of muscle-acting drugs. Common scenarios include intentional overdose, misuse of medications, or exposure to these substances as part of a violent act. The "other" designation implies the agent is not a more defined muscle-acting drug (e.g., neuromuscular blockers, anticholinesterases).

Risk Factors

  • Exposure to medications with muscle-acting properties in non-therapeutic settings.
  • Situations involving coercion or forced administration.
  • Access to drugs with muscle-acting effects in environments where assault is possible.
  • Concurrent use of multiple drugs with overlapping muscle effects, increasing toxicity risk.
  • Vulnerable populations at higher risk of assault-related exposure.

Symptoms

  • Muscle weakness or paralysis.
  • Respiratory depression or difficulty breathing.
  • Dizziness, confusion, or altered mental status.
  • Nausea, vomiting, or gastrointestinal distress.
  • Hypotension or cardiovascular instability.

Diagnosis

Clinical evaluation focuses on symptoms, medication history, and details of the assault. Laboratory tests may assess drug levels, while imaging or other studies rule out concurrent injuries. Documentation of the assault context is critical for accurate coding.

Treatment Options

Treatment involves stabilizing the patient, managing symptoms (e.g., respiratory support, antidotes if available), and addressing any injuries from the assault. Decontamination, if appropriate, and monitoring for complications are standard. Psychological support may be needed for assault-related trauma.

Prognosis and Follow-Up

Prognosis depends on the drug involved, dose, and timeliness of care. Follow-up includes monitoring for delayed effects, assessing for underlying injuries, and addressing mental health needs related to the assault. Long-term outcomes vary based on the severity of poisoning and assault-related harm.

Complications

  • Respiratory failure requiring mechanical ventilation.
  • Prolonged muscle weakness or paralysis.
  • Cardiovascular instability or shock.
  • Neurological damage from hypoxia or drug toxicity.
  • Psychological trauma from the assault.

Lifestyle & Prevention

Prevention focuses on secure storage of medications, avoiding situations with high assault risk, and education on recognizing and reporting suspicious activities. For healthcare providers, ensuring proper medication handling and patient safety protocols can reduce exposure.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning (e.g., difficulty breathing, muscle weakness) occur after an assault. Emergency care is critical for stabilizing the patient and addressing potential life-threatening effects.

Tips for Medical Coders

Document the assault context clearly, including details of exposure and intent. Ensure the "other" designation is used appropriately when the specific muscle-acting drug is not otherwise classified. Verify that the code aligns with clinical documentation of the poisoning event and assault circumstances.

Book a walkthrough

T48.293 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.